Horizon Investments, LLC Biomarin Pharmaceutical Inc Transaction History

Horizon Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $449,333 - $530,164	5,469 New	5,469 $464,000
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $692,498 - $841,402	-9,688 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $1,708 - $2,131	23 Added 0.24%	9,688 $747,000
Q4 2021 Feb 15, 2022	BUY	$71.72 - $91.47 $43,462 - $55,430	606 Added 6.69%	9,665 $854,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $65,348 - $74,700	-874 Reduced 8.8%	9,059 $700,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $522,831 - $587,085	6,924 Added 230.11%	9,933 $829,000
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $53,805 - $65,296	-720 Reduced 19.31%	3,009 $227,000
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $270,762 - $336,355	3,729 New	3,729 $327,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Investments, LLC with notifications on news.